Stay updated on SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma

Sign up to get notified when there's something new on the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page.
Latest website image capture
Clouds background image

Latest updates to the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page's revision identifier was updated from v3.5.3 to v3.5.4, indicating a new iteration of the page that likely includes small edits or metadata changes.
    Difference
    0.0%
    Check dated 2026-05-15T05:37:30.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s footer revision/version label was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T05:46:49.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T02:34:49.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 on the page metadata.
    Difference
    0.0%
    Check dated 2026-03-19T04:25:10.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    - Revision: v3.4.3 was added. - Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-11T20:10:08.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; the previous notices including Revision: v3.4.1 about government funding lapse and NIH Clinical Center operating status were removed.
    Difference
    0.4%
    Check dated 2026-02-11T05:55:35.000Z thumbnail image

Stay in the know with updates to SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma

Enter your email address, and we'll notify you when there's something new on the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page.